BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8529742)

  • 1. Flow cytometric DNA studies and AgNOR counts in patients with transitional cell carcinoma of the bladder.
    Celikel C; Dillioğlugil O; Türkeri LN; Başaran M; Yalçiner A; Küllü S; Akdaş A
    Eur Urol; 1995; 28(2):152-7. PubMed ID: 8529742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
    Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
    Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Argyrophilic nucleolar organizer region in proliferating cell has a predictive value for local recurrence in superficial bladder tumor.
    Tomobe M; Shimazui T; Uchida K; Hinotsu S; Akaza H
    J Urol; 1999 Jul; 162(1):63-8. PubMed ID: 10379741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silver-stained nucleolar organizer regions in normal and dysplastic cervical lesions: correlation with DNA ploidy and S-phase fraction by flow cytometry.
    Singh M; Prasad S; Kalra N; Singh U; Shukla Y
    Oncology; 2006; 71(5-6):411-6. PubMed ID: 17785995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the argyrophilic nucleolar organizer regions in tumor detection and prognosis.
    Pich A; Chiusa L; Margaria E
    Cancer Detect Prev; 1995; 19(3):282-91. PubMed ID: 7750118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interphase argyrophilic nucleolar organiser regions and nucleolar counts in transitional cell bladder tumours.
    Korneyev IA; Mamaev NN; Kozlov VV; Rybakova MG; al-Shukri SH
    Mol Pathol; 2000 Jun; 53(3):129-32. PubMed ID: 10897331
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ureteropelvic transitional cell carcinoma with bladder transitional cell carcinoma using an image analyzer.
    Shiina H; Igawa M; Urakami S; Shirakawa H; Ishibe T
    Urol Int; 1996; 56(3):163-8. PubMed ID: 8860737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AgNOR counts and histological grade in stage pTa bladder tumours: reproducibility and relation to recurrence pattern.
    Hansen AB; Bjerregaard B; Ovesen H; Horn T
    Histopathology; 1992 Mar; 20(3):257-62. PubMed ID: 1563712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of argyrophilic nucleolar organizer regions (AgNORs) and mitotic index in distinguishing benign from malignant canine smooth muscle tumors and in separating inflammatory hyperplasia from neoplastic lesions of the urinary bladder mucosa.
    Johnson GC; Miller MA; Ramos-Vara JA
    J Vet Diagn Invest; 1995 Jan; 7(1):127-36. PubMed ID: 7779947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical value of argyrophilic organizer region in bladder transitional cell carcinoma.
    Shiina H; Shirakawa H; Yokogi H; Kishi H; Mizutani M; Igawa M; Ishibe T
    Urol Int; 1995; 54(2):74-9. PubMed ID: 7747363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of DNA ploidy pattern and nucleolar organizer regions (AgNOR) in colorectal carcinoma.
    Eminović-Behrem S; Trobonjaca Z; Petrovecki M; Dobi-Babić R; Dujmović M; Jonjić N
    Croat Med J; 2000 Jun; 41(2):154-8. PubMed ID: 10853043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinic cell carcinoma of salivary glands. Prognostic relevance of DNA flow cytometry and nucleolar organizer regions.
    Timon CI; Dardick I; Panzarella T; Patterson B; Thomas MJ; Ellis GL; Gullane PJ
    Arch Otolaryngol Head Neck Surg; 1994 Jul; 120(7):727-33. PubMed ID: 8018325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AgNORs in ductal breast cancer: correlation with ploidy and S-phase fraction by DNA flow cytometry.
    Borgiani L; Cogorno P; Oliviero J; Toso F; Gambini G; Tunesi G; Canepa M
    Eur J Histochem; 1994; 38(2):171-6. PubMed ID: 7524814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AgNOR/P53 expression compared with different grades in bladder carcinoma.
    Karakök M; Aydin A; Bakir K; Uçak R; Korkmaz C
    Int Urol Nephrol; 2001; 33(2):353-5. PubMed ID: 12092655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Silver-binding nucleolar organizer regions (AgNORs) in benign and malignant breast lesions: correlations with ploidy and growth phase by DNA flow cytometry.
    Giri DD; Nottingham JF; Lawry J; Dundas SA; Underwood JC
    J Pathol; 1989 Apr; 157(4):307-13. PubMed ID: 2715879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear DNA content and nucleolar organizer regions in colorectal cancer.
    Adachi Y; Kido A; Mori M; Matsushima T; Shimono R; Inoue T; Sugimachi K
    J Surg Oncol; 1995 Jul; 59(3):177-80. PubMed ID: 7609524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of nucleolar organiser regions and DNA flow cytometry in the evaluation of pleural effusion.
    Huang MS; Tsai MS; Hwang JJ; Wang TH
    Thorax; 1994 Nov; 49(11):1152-6. PubMed ID: 7831633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argyrophilic nucleolar organizer regions in cells of thymoma and thymic carcinoma: correlation with DNA ploidy and clinicopathologic characteristics.
    Lee YC; Chern JH; Pan CC; Chang SC; Perng RP
    Chest; 1999 Apr; 115(4):1115-9. PubMed ID: 10208217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas.
    Pich A; Chiusa L; Comino A; Navone R
    Virchows Arch; 1994; 424(2):143-8. PubMed ID: 7910097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative assessment of proliferating cell nuclear antigen immunostaining and of nucleolar organizer region staining in transitional cell carcinomas of the urinary bladder. Correlation with other conventional prognostic pathologic parameters.
    Skopelitou A; Korkolopoulou P; Papanicolaou A; Christodoulou P; Thomas-Tsagli E; Pavlakis K
    Eur Urol; 1992; 22(3):235-40. PubMed ID: 1361436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.